241 related articles for article (PubMed ID: 10051540)
1. Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease.
Khélifa T; Beck WT
Mol Pharmacol; 1999 Mar; 55(3):548-56. PubMed ID: 10051540
[TBL] [Abstract][Full Text] [Related]
2. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
Kusumoto H; Rodgers QE; Boege F; Raimondi SC; Beck WT
Cancer Res; 1996 Jun; 56(11):2573-83. PubMed ID: 8653700
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-Jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells.
Khélifa T; Beck WT
Biochem Pharmacol; 1999 Oct; 58(8):1247-57. PubMed ID: 10487526
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways.
Jun CD; Oh CD; Kwak HJ; Pae HO; Yoo JC; Choi BM; Chun JS; Park RK; Chung HT
J Immunol; 1999 Mar; 162(6):3395-401. PubMed ID: 10092794
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and activation of interleukin 1beta-converting enzyme/Ced-3 protease (caspase-3) and c-Jun NH2-terminal kinase 1 by benzo(a)pyrene.
Lei W; Yu R; Mandlekar S; Kong AN
Cancer Res; 1998 May; 58(10):2102-6. PubMed ID: 9605752
[TBL] [Abstract][Full Text] [Related]
6. Requirement of protein kinase (Krs/MST) activation for MT-21-induced apoptosis.
Watabe M; Kakeya H; Osada H
Oncogene; 1999 Sep; 18(37):5211-20. PubMed ID: 10498871
[TBL] [Abstract][Full Text] [Related]
7. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
8. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways.
Jun CD; Pae HO; Kwak HJ; Yoo JC; Choi BM; Oh CD; Chun JS; Paik SG; Park YH; Chung HT
Cell Immunol; 1999 May; 194(1):36-46. PubMed ID: 10357879
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of UV-induced apoptosis in human leukemia cells: roles of Ca2+/Mg(2+)-dependent endonuclease, caspase-3, and stress-activated protein kinases.
Kimura C; Zhao QL; Kondo T; Amatsu M; Fujiwara Y
Exp Cell Res; 1998 Mar; 239(2):411-22. PubMed ID: 9521859
[TBL] [Abstract][Full Text] [Related]
10. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death.
Robertson NM; Zangrilli J; Fernandes-Alnemri T; Friesen PD; Litwack G; Alnemri ES
Cancer Res; 1997 Jan; 57(1):43-7. PubMed ID: 8988038
[TBL] [Abstract][Full Text] [Related]
11. Merbarone induces activation of caspase-activated DNase and excision of chromosomal DNA loops from the nuclear matrix.
Otake Y; Mims A; Fernandes DJ
Mol Pharmacol; 2006 Apr; 69(4):1477-85. PubMed ID: 16434617
[TBL] [Abstract][Full Text] [Related]
12. Caspase-mediated activation of a 36-kDa myelin basic protein kinase during anticancer drug-induced apoptosis.
Kakeya H; Onose R; Osada H
Cancer Res; 1998 Nov; 58(21):4888-94. PubMed ID: 9809995
[TBL] [Abstract][Full Text] [Related]
13. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
Mandlekar S; Yu R; Tan TH; Kong AN
Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells.
Turner NA; Xia F; Azhar G; Zhang X; Liu L; Wei JY
J Mol Cell Cardiol; 1998 Sep; 30(9):1789-801. PubMed ID: 9769235
[TBL] [Abstract][Full Text] [Related]
15. Teniposide-resistant CEM cells, which express mutant DNA topoisomerase II alpha, when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme.
Chen M; Beck WT
Cancer Res; 1993 Dec; 53(24):5946-53. PubMed ID: 8261408
[TBL] [Abstract][Full Text] [Related]
16. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
17. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis.
Kangas A; Nicholson DW; Hölttä E
Oncogene; 1998 Jan; 16(3):387-98. PubMed ID: 9467964
[TBL] [Abstract][Full Text] [Related]
19. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lu J
Cancer Res; 2001 Apr; 61(7):3062-70. PubMed ID: 11306488
[TBL] [Abstract][Full Text] [Related]
20. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
Geley S; Hartmann BL; Hattmannstorfer R; Löffler M; Ausserlechner MJ; Bernhard D; Sgonc R; Strasser-Wozak EM; Ebner M; Auer B; Kofler R
Oncogene; 1997 Nov; 15(20):2429-37. PubMed ID: 9395239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
